Gabelli Healthcare & WellnessRx Trust

GRX · NYSE · Financial Services / Asset Management

10.41USD-0.01 (-0.10%)

Price History

Full chart

Market Stats

Previous Close10.42

Open10.43

Day Range10.32 – 10.50

52-Week Range8.32 – 10.02

Volume9.78K

Market Cap142.97M

P/E (TTM)17.25

Forward P/E0.00

EPS0.57

Dividend Yield6.94%

50-Day Avg9.84

200-Day Avg9.50

About

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Company Details

SectorFinancial Services
IndustryAsset Management
CEOMr. Wayne Christopher Pinsent C.F.A.
Employees0
HeadquartersOne Corporate Center, Rye, NY, United States, 10580-1422, USA
Websitehttps://www.gabelli.com/Template/fundinfo.cfm?tid=

Leadership

Mr. Wayne Christopher Pinsent C.F.A.Assistant Vice President and Ombudsman · b. 1986
Mr. Mario Joseph Gabelli C.F.A.Portfolio Manager · b. 1942
Mr. Bruce N. Alpert CPAExecutive Vice President & Chief Operating Officer · b. 1952
Mr. Adam E. TokarVice President · b. 1980
Mr. Carter W. AustinSenior Vice President · b. 1966
Mr. David I. SchachterVice President · b. 1953
Mr. Kevin V. DreyerPortfolio Manager
Mr. Jeffrey J. Jonas Jr., C.F.A., Jr.Portfolio Manager

Financials

Income Statement

Currency: USD	2007-12-31	2008-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.52M	898.33K	32.50M	-1.53M	53.76M	25.01M	43.49M	-46.71M	4.01M	3.26M	15.28M
Growth (%)	-	-41.07%	+3518.02%	-104.71%	+3611.29%	-53.48%	+73.93%	-207.41%	+108.59%	-18.81%	+368.67%
Cost of Revenue	434.21K	845.68K	2.96M	3.00M	2.90M	2.69M	5.00M	3.41M	2.77M	2.92M	2.48M
Gross Profit	1.09M	52.65K	32.50M	-1.53M	53.76M	25.01M	43.49M	-46.71M	1.24M	342.91K	12.79M
Gross Margin	71.52%	5.86%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	30.89%	10.52%	83.74%
Operating Expense	251.24K	628.93K	812.77K	748.07K	600.65K	823.72K	751.27K	-2.45M	-1.96M	-2.34M	8.05M
Operating Income	838.95K	-576.28K	31.69M	-2.28M	53.16M	24.18M	42.74M	-44.26M	3.20M	2.68M	4.74M
Operating Margin	55.03%	-64.15%	97.50%	148.86%	98.88%	96.71%	98.27%	94.76%	79.82%	82.32%	31.04%
EBITDA	-	-	31.69M	-2.28M	53.16M	24.18M	42.74M	-44.26M	3.20M	2.68M	4.77M
EBITDA Margin	-	-	97.50%	148.86%	98.88%	96.71%	98.27%	94.76%	79.82%	82.32%	31.22%
Net Income	697.31K	-15.02M	31.69M	-2.28M	53.16M	24.18M	42.74M	-47.44M	422.80K	-285.00K	2.29M
Net Income Margin	45.74%	-1672.43%	97.50%	148.87%	98.88%	96.71%	98.27%	101.56%	10.53%	-8.74%	15.02%
Interest Expense	0	0	94	117	0	57.78K	1.94M	3.18M	2.77M	2.92M	2.47M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	-0.01%	0.00%	0.23%	4.46%	-6.80%	69.11%	89.48%	16.19%

Balance Sheet

Currency: USD	2007-12-31	2008-12-31	2010-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	69.78M	53.45M	-	300.76M	272.34M	307.03M	286.49M	350.84M	248.70M	239.04M	225.71M	241.89M
Total Liabilities	1.71M	829.91K	-	1.08M	688.26K	570.85K	44.32M	86.88M	44.04M	54.23M	54.85M	83.38M
Total Equity	68.07M	52.62M	-	299.68M	271.65M	305.77M	242.17M	263.95M	204.65M	184.81M	170.86M	158.51M
Cash	6.52K	722	-	-	6.26K	-	11.79K	-	50.49K	2.37K	-	17.98K
Total Debt	-	-	-	-	120	-	40.00M	80.07M	40.00M	53.32M	10.10K	70.72M
Net Debt	-	-	-	-	-6.15K	-	39.99M	68.50K	39.95M	53.32M	10.10K	70.70M

Cash Flow

Currency: USD	2007-12-31	2008-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	697.31K	-15.02M	-	-	-	45.24M	-18.94M	58.11M	-356.48K	-2.33M	9.43M
Investing Cash Flow	-	-	-	-	-	42.56M	-4.85M	47.95M	-67.97K	18.34M	67.63M
Financing Cash Flow	67.27M	-423.72K	-	-	-	-45.22M	18.93M	-58.06M	-6.66M	-13.11M	2.11M
Capital Expenditure	0	0	0	0	0	0	3	0	3	4	3
Free Cash Flow	-	-	-	-	-	45.24M	-18.94M	58.11M	-356.48K	13.11M	9.43M
Dividends Paid	423.72K	423.72K	-	-	-	10.42M	16.52M	16.47M	9.94M	9.37M	10.15M
FCF to OCF	-	-	-	-	-	100.00%	100.00%	100.00%	100.00%	-563.71%	100.00%
Dividend Paid to FCF	-	-	-	-	-	23.03%	-87.20%	28.34%	-2787.67%	71.44%	107.58%

Earnings

Report Date	Sep 4, 2020	Mar 8, 2021	Sep 3, 2021	Mar 9, 2022	Sep 7, 2022	Mar 9, 2023
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	-1.01	2.35	1.65	0.83	-2.73	-0.04
Surprise	-	-	-	-	-	-
Timing	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap142.97M

Enterprise Value0

Trailing P/E17.25

Forward P/E0.00

PEG Ratio0.00

Price / Sales17.06

Price / Book0.93

EPS0.57

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-1374.10%

Return on Assets0.00%

Shares Outstanding14.54M

Shares Float0

Dividend Yield6.94%

Dividend Rate0.68

Payout Ratio119.30%

Dividends

20263×

0.17Sep 16, 20260.17Jun 15, 20260.17Mar 17, 2026

20254×

0.17Dec 12, 20250.17Sep 16, 20250.17Jun 13, 20250.15Mar 17, 2025

20244×

0.15Dec 13, 20240.15Sep 16, 20240.15Jun 13, 20240.15Mar 13, 2024

20234×

0.15Dec 14, 20230.15Sep 14, 20230.15Jun 14, 20230.15Mar 16, 2023

20224×

0.15Dec 8, 20220.15Sep 15, 20220.15Jun 14, 20220.15Mar 16, 2022

20215×

0.36Dec 29, 20210.15Dec 9, 20210.15Sep 15, 20210.15Jun 15, 20210.15Mar 16, 2021

Stock Splits

May 30, 20141035:1000
Jun 13, 20131034:1000